Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-08

FDA Approved: TIMOLOL MALEATE — Original Application (Armas Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved TIMOLOL MALEATE as an Original Application (ANDA) for Armas Pharmaceuticals, a generic ophthalmic solution indicated to reduce intraocular pressure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

ORIG AP for TIMOLOL MALEATE (TIMOLOL MALEATE)